B. W. Robinson - Concepedia

Author

B. W. Robinson

The University of Western Australia ORCID

Also Known As

A.J. CURRIE, B Robinson, B W Robinson, B W S Robinson, B. Robinson, B. W. Robinson, B. W. S. Robinson, B.W. Robinson, B.W.S. ROBINSON, B.W.S. Robinson

221

Publications

10.5K

Citations

H-Index

123

Concepts

All Affiliations

The University of Western Australia Sir Charles Gairdner Hospital Queen Elizabeth II Medical Centre Pathwest Laboratory Medicine Harry Perkins Institute of Medical Research

About

B. W. Robinson is an author at The University of Western Australia specializing in medicine, pathology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	26	1.5K
2	Engineering	10	10	538
3	Business	3	3	91
4	Health Sciences	2	2	105
5	Management	1	1	52

B. W. Robinson

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
Integrative Molecular Characterization of Malignant Pleural Mesothelioma Julija Hmeljak, Francisco Sánchez-Vega, Katherine A. Hoadley, Cancer Discovery	2018	585
Roundabouts : an informational guide B. W. Robinson, Lee Rodegerdts, W Scarborough, Der Unfallchirurg	2000	343
Signalized Intersections: Informational Guide Lee Rodegerdts, Brandon Nevers, B. W. Robinson, Traffic SafetyEngineeringRoad Traffic SafetyIntersection ReconstructionSafety Science	2004	183
Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma Jenette Creaney, Ian M. Dick, Tarek Meniawy, Thorax	2014	144
Increased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural Mesothelioma Michaela B. Kirschner, Yuen Yee Cheng, Bahareh Badrian, Journal of Thoracic Oncology Biomarker (Medicine)Prognostic BiomarkersMalignant Pleural MesotheliomaMedicineBiomarker Target	2012	127
Comparison of Osteopontin, Megakaryocyte Potentiating Factor, and Mesothelin Proteins as Markers in the Serum of Patients with Malignant Mesothelioma Jenette Creaney, Deborah Yeoman, Yvonne Demelker, Journal of Thoracic Oncology SclerostinBone Morphogenic ProteinMalignant MesotheliomaMegakaryocyte Potentiating FactorPathology	2008	124
Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation Anne S. Tsao, O. Wolf Lindwasser, Alex A. Adjei, Journal of Thoracic Oncology Malignant DiseaseMedicineCancer ManagementConsensus ReportPathology	2018	113
A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit Amanda Segal, Gregory F. Sterrett, Felicity Frost, Pathology Year AuditMalignant Pleural MesotheliomaEar MoldingSurgical PathologyDiagnosis	2012	112
Soluble mesothelin-related protein—A blood test for mesothelioma B. W. Robinson, Jenette Creaney, Richard Lake, Lung Cancer HistopathologyPathologyClinical ChemistryMedicineConnective Tissue Disease	2005	106
Soluble Mesothelin-related Protein in an Asbestos-exposed Population Eun‐Kee Park, Alessandra Sandrini, Deborah Yates, American Journal of Respiratory and Critical Care Medicine	2008	101

Page 1